BnH-015B Clinical Trial in Moderate Alzheimer's Disease

NCT06535308 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

92

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer Disease

Interventions

DRUG: BnH-015B 5 mg
DRUG: BnH-015B 10 mg
DRUG: BnH-015B 20 mg
DRUG: BnH-015B 40 mg (Dietary impact)
DRUG: BnH-015B 40 mg
DRUG: BnH-015B 80 mg
DRUG: BnH-015B 160 mg
DRUG: BnH-015B 40 mg (MAD)
DRUG: BnH-015B 80 mg (MAD)
DRUG: BnH-015B 40 mg (Part II)
DRUG: BnH-015B 80 mg (Part II)
DRUG: BnH-015B Placebo (Part II)

Sponsor

BnH Research